RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration
TOKYO--(BUSINESS WIRE)--RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (“RIBOMIC” TSE-Mothers : 4591, President and CEO :...

Unitree Robotics: Stumbling Demos, a Failed Kung Fu Flip, and a 2028 Breakthrough Forecast
Swiggy Share Price: Record Low, Potential Rebound, and Analyst Outlook
Infosys Share Price Falls Nearly 4% on Q2 Guidance Miss: Analyst Targets, 2026 Slide, Buy-or-Sell Debate
El Clásico 2026: Real Madrid Beat Barcelona 1-2 as Mbappé Scores 87th-Minute Winner
Brazil Presidential Election: Lula Reported Victorious in Runoff; Bolsonaro Demands Annulment 













